影視股拉昇走強 2019年中國電影總票房創新高
格隆匯1月2日丨影視股拉昇走強,中廣天擇封漲停,當代明誠、華策影視漲超6%,中國電影、萬達電影、上海電影等跟漲。據國家電影局的相關數據顯示,2019年全國電影總票房達到642.66億元,同比增長5.4%;國產電影總票房411.75億元,同比增長8.65%,市場佔比64.07%;城市院線觀影人次則為17.27億,無論是電影票房還是觀影人次,均再次創造了新高。2019年新增銀幕9708塊,全國銀幕總數達到69787塊。全年票房前10名影片中,國產影片佔8部。全年票房過億元影片88部,其中國產電影47部。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.